北京同仁堂医养投资股份有限公司(下称“同仁堂医养”)今日启动招股,中金公司担任独家保荐人,拟全球发售1.08亿股H股,其中香港公开发售占约10%,国际发售占约90%,另有15%超额配股权。每股发售价7.3-8.3港元,每手500股,一手入场费4191.85港元,预期H股将于2026年3月30日(星期一)上午九时正在联交所开始买卖。作为同仁堂集团旗下专注中医医疗服务的核心版块,公司依托百年老字号品牌...
Source Link北京同仁堂医养投资股份有限公司(下称“同仁堂医养”)今日启动招股,中金公司担任独家保荐人,拟全球发售1.08亿股H股,其中香港公开发售占约10%,国际发售占约90%,另有15%超额配股权。每股发售价7.3-8.3港元,每手500股,一手入场费4191.85港元,预期H股将于2026年3月30日(星期一)上午九时正在联交所开始买卖。作为同仁堂集团旗下专注中医医疗服务的核心版块,公司依托百年老字号品牌...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.